Hunt Jonathan Robert

Chief Financial OfficerPerspective Therapeutics, Inc. (CATX) · full profile →Form 4 · filed Jun 18, 2024
Net Buying
Open-Market Buys
$18K
Open-Market Sells
$0
Net Open-Market Flow
$18K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 17, 2024Buy(P)2K$9.82$18K36K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-074594) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about CATX insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000950170-24-074594"
Ask your agent
Use Arkolith to summarize insider buying and selling at Perspective Therapeutics, Inc.
over the last 90 days and cite the filings.